BioMedGPS is pleased to announce, as of June 2018, all Q118 Ortho, Wound & Neuro Market Recaps and Financial Dashboard Results are available on app.SmartTRAK.com. SmartTRAK is the first real-time business intelligence portal for the Orthopedics, Wound Care and Neuro Therapies markets.
Our daily updates, strategic insights and in-depth analyses by domain experts allow device executives to always be in-the-know and be able to distill relevant insights quickly.
SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 US Spinal Cord Stimulation Market Recap.
The US Spinal Cord Stimulation (SCS) market saw another quarter of exceptional growth in Q118, yet the market decelerated QoQ, posting 23% growth vs 24.6% growth in Q417. While seasonal trends were behind the QoQ slowdown ...Among the many topics covered in the full Q118 SCS Market Recap are:
SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Infection Prevention Market Recap.
For Q118, according to BioMedGPS’ SmartTRAK Financial Dashboard, the US Infection Prevention - Vascular Access Adjunct Products market grew +3.9% YoY. Market gains continue as BD moves into leadership position...
Among the many topics covered in the full Q118 Infection Prevention Market Recap are:
SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Soft Tissue Fixation Market Recap.
Seasonality slowed Soft Tissue Fixation market growth, but the addition of biologics to RC repair implants makes the future promising. The US soft tissue fixation market continued to grow at 3.3% YoY...
Among the many topics covered in the full Q118 Soft Tissue Fixation Market Recap are:
SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Advanced Wound Care Market Recap.
SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 OrthoBio Market Recap.
Up 3.4% YoY, the OrthoBio market is off to a good start. Companies that are surpassing growth expectations tend to have differentiated products, focused efforts and incremental pull through from synergistic sales strategies. Market subtleties like reimbursement, pricing pressures and market loss due to newer competition continue to afflict some companies and segments...
Among the many topics covered in the full Q118 OrthoBio Market Recap are:
In May 2017, Nevro CEO Rami Elghandour chatted with Anne Staylor, BioMedGPS Managing Editor/Neuro Analyst to discuss dynamics in the global spinal cord stimulation (SCS) market, including trends, drivers, challenges, competition, and opportunity that would influence the Company’s growth.
A fascinating read then, that now has us appraising a year later if Elghandour's expansion predictions came to pass. Is Nevro still the one to beat as the top leader in the neuromodulation field?
or read the interview in full below!
SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Spine Market Recap.
While we saw a slight upturn in the market in Q4, the beginning of 2018 has again revealed the Spine market’s true colors – with a slight decline in the overall market and notable pricing pressures. With -1.9% YoY growth, Stryker’s US Spine revenues were challenged by market softness as well as low-double digit (~10%) price declines across core product lines. K2M management reported ...
Among the many topics covered in the Q118 Spine Market Recap are:
SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Hemostats and Sealants Market Recap.
SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Trauma Market Recap.
SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services.